JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, P. L. Articles by Covino, B. G. Search for Related Content PubMed PubMed Citation Articles by Liu, P. L. Articles by Covino, B. G.

Comparative CNS Toxicity of Lidocaine, Etidocaine, Bupivacaine, and Tetracaine in Awake Dogs Following Rapid Intravenous Administration

Department of Anesthesia, Harvard Medical School, Brigham and Women's Hospital, Boston, and the Department of Anesthesiology, University of Massachusetts Medical Center, Worcester, Massachusetts. Presented at the 1981 Annual Meeting of the American Society of Anesthesiologists, New Orleans, Louisiana.

Abstract

The comparative central nervous system (CNS) toxicity of serially administered intravenous doses of lidocaine, bupivacaine, etidocaine, and tetracaine was investigated in awake dogs. The mean cumulative dose required for convulsive activity was 4.0 mg/kg tetracaine, 5.0 mg/kg bupivacaine, 8.0 mg/kg etidocaine, and 22.0 mg/kg lidocaine. The cumulative convulsive dose of lidocaine was significantly greater than that of the other three agents (P < 0.01). A comparison of the in vivo anesthetic potency and the acute CNS toxicity of these various agents suggests little difference in the therapeutic ratio between less potent anesthetics such as lidocaine and more potent drugs, i.e., tetracaine, bupivacaine, and etidocaine. The relative CNS toxicity of the different agents as determined in awake dogs in this study was compared with their relative cardiovascular toxicity previously evaluated in a series of ventilated dogs anesthetized with pentobarbital. The dose of lidocaine, etidocaine, tetracaine, and bupivacaine required to produce irreversible cardiovascular depression was 3.5–6.7 times greater than that which produced convulsions. These results suggest that the CNS is the primary target organ for the toxic effects of both highly lipid-soluble and highly protein-bound local anesthetics (i.e., bupivacaine, etidocaine, and tetracaine) and less lipid-soluble and less protein-bound drugs (i.e., lidocaine) following rapid intravenous administration.

Key Words: ANESTHETICS • Local: lidocaine • bupivacaine • etidocaine • tetracaine • TOXICITY: local anesthetics

This article has been cited by other articles:

				E. I. Eger II, D. E. Raines, S. L. Shafer, H. C. Hemmings Jr, and J. M. Sonner Is a New Paradigm Needed to Explain How Inhaled Anesthetics Produce Immobility? Anesth. Analg., September 1, 2008; 107(3): 832 - 848. [Abstract] [Full Text] [PDF]

				B. P. Hansen, C. L. Beck, E. P. Beck, and R. W. Townsley Postarthroscopic Glenohumeral Chondrolysis Am. J. Sports Med., October 1, 2007; 35(10): 1628 - 1634. [Abstract] [Full Text] [PDF]

				L. Groban, D. D. Deal, J. C. Vernon, R. L. James, and J. Butterworth Ventricular Arrhythmias With or Without Programmed Electrical Stimulation After Incremental Overdosage with Lidocaine, Bupivacaine, Levobupivacaine, and Ropivacaine Anesth. Analg., October 1, 2000; 91(5): 1103 - 1111. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999